Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 43, Issue 5, Pages 416-426
Publisher
Oxford University Press (OUP)
Online
2021-11-24
DOI
10.1093/eurheartj/ehab798
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Failure and a Preserved Ejection Fraction: A Side-by-Side Examination of the PARAGON-HF andEMPEROR-Preserved Trials
- (2021) Milton Packer et al. CIRCULATION
- Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and a Preserved Ejection Fraction: The EMPEROR-Preserved Trial
- (2021) Milton Packer et al. CIRCULATION
- Classification of Heart Failure According to Ejection Fraction
- (2021) Carolyn S.P. Lam et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure
- (2020) Pooja Dewan et al. EUROPEAN JOURNAL OF HEART FAILURE
- Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach
- (2020) Prathap Kanagala et al. PLoS One
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
- (2020) Darren K. McGuire et al. JAMA Cardiology
- Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial
- (2020) Javed Butler et al. EUROPEAN HEART JOURNAL
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sex Differences in Outcomes and Responses to Spironolactone in Heart Failure With Preserved Ejection Fraction
- (2019) Miranda Merrill et al. JACC-Heart Failure
- Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial
- (2019) Milton Packer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?
- (2019) Gregory J Wehner et al. EUROPEAN HEART JOURNAL
- Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial
- (2019) Stefan D. Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- Redefining Heart Failure With a Reduced Ejection Fraction
- (2019) Javed Butler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF
- (2019) John J. V. McMurray et al. CIRCULATION
- Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
- (2019) Scott D. Solomon et al. CIRCULATION
- Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum
- (2018) Lars H. Lund et al. EUROPEAN JOURNAL OF HEART FAILURE
- Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction
- (2017) Jasper Tromp et al. Journal of the American Heart Association
- Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
- (2015) Scott D. Solomon et al. EUROPEAN HEART JOURNAL
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now